aTYR PHARMA INC - FORM 10-K - EX-23.1 - March 16, 2017

Attached files

file filename
EX-31.1 - EX-31.1 - aTYR PHARMA INClife-ex311_14.htm
EX-32.2 - EX-32.2 - aTYR PHARMA INClife-ex322_6.htm
EX-32.1 - EX-32.1 - aTYR PHARMA INClife-ex321_11.htm
EX-31.2 - EX-31.2 - aTYR PHARMA INClife-ex312_12.htm
EX-10.19 - EX-10.19 - aTYR PHARMA INClife-ex1019_1376.htm
EX-10.18 - EX-10.18 - aTYR PHARMA INClife-ex1018_1377.htm
EX-10.17 - EX-10.17 - aTYR PHARMA INClife-ex1017_1754.htm
EX-10.8 - EX-10.8 - aTYR PHARMA INClife-ex108_1378.htm
EX-4.6 - EX-4.6 - aTYR PHARMA INClife-ex46_668.htm
EX-4.5 - EX-4.5 - aTYR PHARMA INClife-ex45_669.htm
10-K - 10-K - aTYR PHARMA INClife-10k_20161231.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

 

 

1.

Registration Statement (Form S-3 No. 333-211998) of aTyr Pharma, Inc.,

 

2.

Registration Statement (Form S-8 No. 333-203955) pertaining to ATYR PHARMA, INC. 2014 STOCK PLAN, ATYR PHARMA, INC. 2015 STOCK OPTION AND INCENTIVE PLAN, and the ATYR PHARMA, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN, and

 

3.

Registration Statement (Form S-8 No. 333-210543) pertaining to the ATYR PHARMA, INC. 2015 STOCK OPTION AND INCENTIVE PLAN, and the ATYR PHARMA, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN;

of our report dated March 16, 2017, with respect to the consolidated financial statements of aTyr Pharma, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2016.

 

/s/ Ernst & Young LLP

 

San Diego, California

March 16, 2017

 

aTYR PHARMA INC Reports